Landon S Hoecker, MD | |
7150 E Camelback Rd, Suite 105, Scottsdale, AZ 85251-1200 | |
(602) 218-4072 | |
(602) 218-4076 |
Full Name | Landon S Hoecker |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 33 Years |
Location | 7150 E Camelback Rd, Scottsdale, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740260561 | NPI | - | NPPES |
692774 | Medicaid | AZ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 30150 (Arizona) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Iora Senior Health, Inc | 0143520189 | 88 |
News Archive
New analyses from the Women's Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. Researchers report a trend toward an increased risk of heart disease during the first two years of hormone therapy among women who began therapy within 10 years of menopause, and a more marked elevation of risk among women who began hormone therapy more than 10 years after menopause. Analyses indicate that overall a woman's risk of heart disease more than doubles within the first two years of taking combination HT.
Leading medical experts today [Thursday 27 November] warn that rising numbers of deaths from liver disease - already the UK's third commonest cause of premature death - will be unavoidable without radical improvements in treatment and detection services, and tougher government policies to control the excessive alcohol use and obesity responsible for much of the national burden of liver disease.
Adolescents with strong working memory are better equipped to escape early drug experimentation without progressing into substance abuse issues, says a University of Oregon researcher.
Broadening the reach of two of its flagship aesthetic laser products into the Asia Pacific region, Cynosure, Inc. today announced that it has received approval to market the Smartlipo MPX(TM) LaserBodySculpting(SM) Workstation in Korea and the Affirm(TM) Anti-Aging Workstation in the People's Republic of China.
Combining the new drug trabectedin with pegylated liposomal doxorubicin provides clinical benefit to women with relapsed ovarian cancer, according to new results presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
› Verified 4 days ago
Entity Name | Honorhealth Ambulatory |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407050917 PECOS PAC ID: 5991603110 Enrollment ID: O20071005000449 |
News Archive
New analyses from the Women's Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. Researchers report a trend toward an increased risk of heart disease during the first two years of hormone therapy among women who began therapy within 10 years of menopause, and a more marked elevation of risk among women who began hormone therapy more than 10 years after menopause. Analyses indicate that overall a woman's risk of heart disease more than doubles within the first two years of taking combination HT.
Leading medical experts today [Thursday 27 November] warn that rising numbers of deaths from liver disease - already the UK's third commonest cause of premature death - will be unavoidable without radical improvements in treatment and detection services, and tougher government policies to control the excessive alcohol use and obesity responsible for much of the national burden of liver disease.
Adolescents with strong working memory are better equipped to escape early drug experimentation without progressing into substance abuse issues, says a University of Oregon researcher.
Broadening the reach of two of its flagship aesthetic laser products into the Asia Pacific region, Cynosure, Inc. today announced that it has received approval to market the Smartlipo MPX(TM) LaserBodySculpting(SM) Workstation in Korea and the Affirm(TM) Anti-Aging Workstation in the People's Republic of China.
Combining the new drug trabectedin with pegylated liposomal doxorubicin provides clinical benefit to women with relapsed ovarian cancer, according to new results presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
› Verified 4 days ago
Entity Name | Omg Arizona, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184014854 PECOS PAC ID: 9638499247 Enrollment ID: O20150522000007 |
News Archive
New analyses from the Women's Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. Researchers report a trend toward an increased risk of heart disease during the first two years of hormone therapy among women who began therapy within 10 years of menopause, and a more marked elevation of risk among women who began hormone therapy more than 10 years after menopause. Analyses indicate that overall a woman's risk of heart disease more than doubles within the first two years of taking combination HT.
Leading medical experts today [Thursday 27 November] warn that rising numbers of deaths from liver disease - already the UK's third commonest cause of premature death - will be unavoidable without radical improvements in treatment and detection services, and tougher government policies to control the excessive alcohol use and obesity responsible for much of the national burden of liver disease.
Adolescents with strong working memory are better equipped to escape early drug experimentation without progressing into substance abuse issues, says a University of Oregon researcher.
Broadening the reach of two of its flagship aesthetic laser products into the Asia Pacific region, Cynosure, Inc. today announced that it has received approval to market the Smartlipo MPX(TM) LaserBodySculpting(SM) Workstation in Korea and the Affirm(TM) Anti-Aging Workstation in the People's Republic of China.
Combining the new drug trabectedin with pegylated liposomal doxorubicin provides clinical benefit to women with relapsed ovarian cancer, according to new results presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
› Verified 4 days ago
Entity Name | Iora Senior Health, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619376456 PECOS PAC ID: 0143520189 Enrollment ID: O20151124001666 |
News Archive
New analyses from the Women's Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. Researchers report a trend toward an increased risk of heart disease during the first two years of hormone therapy among women who began therapy within 10 years of menopause, and a more marked elevation of risk among women who began hormone therapy more than 10 years after menopause. Analyses indicate that overall a woman's risk of heart disease more than doubles within the first two years of taking combination HT.
Leading medical experts today [Thursday 27 November] warn that rising numbers of deaths from liver disease - already the UK's third commonest cause of premature death - will be unavoidable without radical improvements in treatment and detection services, and tougher government policies to control the excessive alcohol use and obesity responsible for much of the national burden of liver disease.
Adolescents with strong working memory are better equipped to escape early drug experimentation without progressing into substance abuse issues, says a University of Oregon researcher.
Broadening the reach of two of its flagship aesthetic laser products into the Asia Pacific region, Cynosure, Inc. today announced that it has received approval to market the Smartlipo MPX(TM) LaserBodySculpting(SM) Workstation in Korea and the Affirm(TM) Anti-Aging Workstation in the People's Republic of China.
Combining the new drug trabectedin with pegylated liposomal doxorubicin provides clinical benefit to women with relapsed ovarian cancer, according to new results presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Landon S Hoecker, MD 7150 E Camelback Rd, Suite 105, Scottsdale, AZ 85251-1200 Ph: (602) 218-4072 | Landon S Hoecker, MD 7150 E Camelback Rd, Suite 105, Scottsdale, AZ 85251-1200 Ph: (602) 218-4072 |
News Archive
New analyses from the Women's Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. Researchers report a trend toward an increased risk of heart disease during the first two years of hormone therapy among women who began therapy within 10 years of menopause, and a more marked elevation of risk among women who began hormone therapy more than 10 years after menopause. Analyses indicate that overall a woman's risk of heart disease more than doubles within the first two years of taking combination HT.
Leading medical experts today [Thursday 27 November] warn that rising numbers of deaths from liver disease - already the UK's third commonest cause of premature death - will be unavoidable without radical improvements in treatment and detection services, and tougher government policies to control the excessive alcohol use and obesity responsible for much of the national burden of liver disease.
Adolescents with strong working memory are better equipped to escape early drug experimentation without progressing into substance abuse issues, says a University of Oregon researcher.
Broadening the reach of two of its flagship aesthetic laser products into the Asia Pacific region, Cynosure, Inc. today announced that it has received approval to market the Smartlipo MPX(TM) LaserBodySculpting(SM) Workstation in Korea and the Affirm(TM) Anti-Aging Workstation in the People's Republic of China.
Combining the new drug trabectedin with pegylated liposomal doxorubicin provides clinical benefit to women with relapsed ovarian cancer, according to new results presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
› Verified 4 days ago
Dr. Sam Saman Fereidouni, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7699 E Pinnacle Peak Rd, Suite 115, Scottsdale, AZ 85255 Phone: 480-300-4663 Fax: 480-300-4888 | |
Dr. Daniel Andrew Wool, ND Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 20801 N Scottsdale Rd Suite 205, Scottsdale, AZ 85255 Phone: 480-389-3265 | |
Helene Wechsler, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10900 N Scottsdale Rd, Suite 104, Scottsdale, AZ 85254 Phone: 480-990-1564 Fax: 480-990-3298 | |
Natasha Ryan, NMD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8412 E Shea Blvd, Suite 101, Scottsdale, AZ 85260 Phone: 480-874-1515 Fax: 480-991-8395 | |
Evan Scot Trost Ix, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8328 E. Hartford Dr., Scottsdale, AZ 85255 Phone: 480-214-9720 Fax: 480-214-9722 | |
Katayoun Baniriah, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 4845 E Thunderbird Rd, Scottsdale, AZ 85254 Phone: 480-699-7004 Fax: 480-699-6129 | |
Dr. Ronald Lewis Peters, MD, MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13951 N Scottsdale Rd, Suite 100, Scottsdale, AZ 85254 Phone: 480-607-7999 Fax: 480-607-7998 |